Introduction
Gastrointestinal bleeding from an unknown or inaccessible site in a patient who may not be fit for surgery presents a difficult and not uncommon problem. The following case illustrates an effective and simple form of therapy.
Case report
A previously well 79-year-old woman presented with a short history of breathlessness. She had been on no drug therapy apart from iron tablets. She drank no alcohol, ate an adequate diet and denied dyspepsia and melaena. Examination showed her to be pale. She had a regular pulse of 90/min and a blood pressure of 150/90 mmHg. A systolic murmur was audible over the whole precordium, the jugular veins were elevated to the jaw, there was no peripheral oedema, but she had bilateral basal crepitations. The provisional diagnosis was cardiac failure secondary to anaemia. Investigation showed her haemoglobin was 5-8 g/dl, white cell count 1 1-1 x 109/litre, the film showed a normochromic normocytic picture. Blood urea, electrolytes and glucose were normal. Over the next 12 hr she became worse and her haemoglobin fell to 4-7 g/dl. She was treated with diuretics and transfused. After five units of blood her congestive cardiac failure was improving. Following transfusion her haemoglobin began to fall again and she then passed a melaena stool. Gastroscopy was performed which showed a friable atrophic mucosa, no fresh blood in the stomach, though blood was seen coming from the second part She had by then been in hospital for two weeks and had been transfused several times, but her haemoglobin continued to fall. Repeat gastroscopy showed similar findings. She had been treated empirically with cimetidine and later tripotassium dicitrato bismuthate (De-Nol). Because of continued bleeding from the gut mesenteric angiography was thought justified despite her age. This showed a steady ooze from the second part of the duodenum and an angiomatous malformation was not seen (Figs. 1, 2). Deterioration continued and further transfusion was required. A laparotomy was performed on the 40th hospital day which showed mild duodenitis and gastritis. The duodenum was opened and a hypertrophic fold ofmucosa below the ampulla of Vater was bleeding and was oversewn. Two feet of jejunum were dissected out and thought to be normal. The gall bladder was also normal.
Postoperatively she made a good recovery and was initially quite well, but on the fourth postoperative day she passed a large melaena stool and her haemoglobin again fell. She was given 2 units of fresh frozen plasma and started on aminocaproic acid 3 g six hourly. Her haemoglobin was restored to 14 g/dl after transfusion. Once started on this antifibrinolytic therapy her haemoglobin was maintained within normal limits and remains so some two months afterward. It is interesting to see how her haemoglobin fell with time when plotted on a graph (Fig. 3) plasmin, thus inactivating the natural action of the fibrinolytic system, leaving the action of the coagulation system unopposed (Prentice, 1979) . It is known that there is an increased concentration of tissue plasminogen activator occurring at certain sites; these include the uterus, the prostate and the cerebrospinal fluid following subarachnoid haemorrhage. The role of anti-fibrinolytic agents in bleeding from these sites is well established (Anderson, 1972; Callender, Warner and Cope, 1970; Gibbs and Corhill, 1971; Sack et al., 1972) . Regarding the gastrointestinal tract, Cox, Poller and Thompson (1967a) demonstrated increased plasminogen activator and plasmin in the gastric mucosa and gastric vein. They later showed in patients with peptic ulceration increased euglobulin clot lysis time in peripheral blood after handling of the stomach at laparotomy (Cox et al., 1967b In general these studies above used the antifibrinolytic agent tranexamic acid rather than aminocaproic acid. Recently it has been shown (Nilsson, 1979) by both in vivo and in vitro assay that tranexamic acid is 7-10 times more powerful than aminocaproic acid (Andersson et aL, 1968) .
The experience of this detailed case study in a single patient would seem to be in keeping with the findings of the large series previously studied, in that antifibrinolytic agents may have a place in the management of a minority of patients with upper gastrointestinal bleeding. The bleeding was controlled after starting aminocaproic acid, but was not affected by surgery. The nature of the bleeding site in the above case is not really known, though it would appear to be from the duodenal mucosa. It is unlikely that the patient would have survived a duodenal resection which is probably the only definitive form of surgery that would have stopped the bleeding. The number of patients with endoscopic negative gastrointestinal bleeding who continue to bleed in a lifethreatening fashion is fortunately small. Our experience with the one patient would suggest that antifibrinolytic agents should be given a trial, particularly in those unfit for surgery. Further study of the plasmin and coagulation systems should be made in these patients as the problem may be there rather than primarily in the mucosa.
